CMPS net incomeQ3 2026-$9.83M
CMPS net income was -$9.83M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$137.72M a year earlier. For the full fiscal 2025 it was -$287.86M, compared with -$155.12M in fiscal 2024.
COMPASS Pathways Plc (CMPS) financials
For the twelve months ended Sep 30, 2026, COMPASS Pathways Plc reported -$266.30M of net income.
- Net income, TTM
- -$266.30M
- EPS, diluted, TTM
- -$3.48
- Cash
- $443.98M
- Total debt
- $50.99M
- Market cap
- $1.31B
FY2019FY2025
FY2019FY2024
CMPS revenue and earnings growth
CMPS EPSQ3 2026-$0.31
CMPS diluted EPS was -$0.31 in fiscal Q3 2026 (ended Sep 30, 2026). For the full fiscal 2025 it was -$3.08, compared with -$2.30 in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Research and development | $118.44M | $119.04M | $87.52M | $65.05M | $44.03M | $23.37M | $12.56M |
| Selling, general and admin | $60.60M | $59.17M | $49.40M | $45.35M | $39.19M | $28.03M | $8.62M |
| Operating income | -$179.04M | -$178.21M | -$136.92M | -$110.40M | -$83.22M | -$51.39M | -$21.18M |
| Interest expense | $4.52M | $4.48M | $2.20M | $0 | $0 | - | - |
| Pre-tax income | -$290.33M | -$153.53M | -$117.68M | -$91.10M | -$71.54M | -$60.30M | -$19.60M |
| Income tax | -$2.47M | $1.59M | $780.0K | $408.0K | $199.0K | $32.0K | $15.0K |
| Net income | -$287.86M | -$155.12M | -$118.46M | -$91.50M | -$71.74M | -$60.33M | -$19.61M |
| EPS, basic | -$3.08 | -$2.30 | -$2.32 | -$2.16 | -$1.79 | -$3.55 | -$2.62 |
| EPS, diluted | -$3.08 | -$2.30 | -$2.32 | -$2.16 | -$1.79 | -$3.55 | -$2.62 |
| Diluted shares | 93.5M | 67.5M | 51.0M | 42.4M | 40.0M | 17.0M | 7.5M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $149.61M | $165.47M | $220.64M | $143.38M | $273.24M | $190.36M | $24.98M |
| Current assets | $191.49M | $201.29M | $261.30M | $191.65M | $295.30M | $202.40M | $32.17M |
| Total assets | $210.35M | $213.67M | $275.99M | $197.29M | $300.90M | $203.46M | $32.39M |
| Current liabilities | $247.79M | $34.02M | $19.60M | $15.60M | $15.11M | $6.89M | $23.87M |
| Short-term debt | $17.52M | $5.51M | $0 | - | - | - | - |
| Long-term debt | $14.11M | $24.65M | $28.76M | - | - | - | - |
| Total debt | $31.63M | $30.16M | $28.76M | $0 | - | - | - |
| Total liabilities | $263.20M | $58.97M | $50.24M | $16.01M | $16.49M | $6.89M | $23.87M |
| Shareholders' equity | -$52.85M | $154.69M | $225.74M | $181.28M | $284.41M | $196.56M | -$30.39M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$157.24M | -$119.19M | -$97.38M | -$105.45M | -$67.75M | -$41.38M | -$17.81M |
| Capital expenditures | - | $0 | $66.0K | $596.0K | $334.0K | $131.0K | $165.0K |
| Free cash flow | - | -$119.19M | -$97.44M | -$106.05M | -$68.08M | -$41.51M | -$17.98M |
| Investing cash flow | - | $0 | -$64.0K | -$596.0K | -$334.0K | -$628.0K | -$165.0K |
| Financing cash flow | $140.71M | $63.82M | $173.83M | $1.04M | $156.65M | $194.16M | $18.38M |
| Stock-based compensation | $13.59M | $19.52M | $17.28M | $13.12M | $8.64M | $17.98M | $3.25M |
| Depreciation and amortization | - | - | $242.0K | $330.0K | $175.0K | $112.0K | $63.0K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Return on equity | - | -100.3% | -52.5% | -50.5% | -25.2% | -30.7% | - |
| Return on assets | -136.8% | -72.6% | -42.9% | -46.4% | -23.8% | -29.7% | -60.6% |
| Current ratio | 0.77 | 5.92 | 13.33 | 12.29 | 19.55 | 29.36 | 1.35 |
| Debt to equity | - | 0.19 | 0.13 | 0.00 | - | - | - |
Income statement
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $23.46M | $29.18M | $26.48M | $29.91M | $27.32M | $30.32M | $30.88M | $32.14M | $32.93M | $29.07M | $24.90M | $27.14M |
| Selling, general and admin | $32.98M | $23.20M | $16.42M | $16.05M | $13.21M | $12.61M | $18.74M | $16.27M | $14.97M | $14.25M | $13.67M | $11.27M |
| Operating income | -$56.44M | -$52.37M | -$42.90M | -$45.95M | -$40.54M | -$42.93M | -$49.62M | -$48.41M | -$47.90M | -$43.32M | -$38.57M | -$38.41M |
| Interest expense | $1.50M | $1.48M | $1.47M | $1.14M | $1.10M | $1.15M | $1.12M | $1.13M | $1.14M | $1.11M | $1.10M | $1.12M |
| Pre-tax income | -$10.94M | -$253.46M | $91.19M | -$96.61M | -$137.95M | -$38.27M | -$17.51M | -$42.31M | -$38.33M | -$37.92M | -$34.97M | -$32.14M |
| Income tax | -$1.11M | $331.0K | -$11.0K | -$2.73M | -$230.0K | $137.0K | $354.0K | $1.02M | $173.0K | $176.0K | $222.0K | $394.0K |
| Net income | -$9.83M | -$253.79M | $91.20M | -$93.88M | -$137.72M | -$38.40M | -$17.86M | -$43.33M | -$38.50M | -$38.10M | -$35.19M | -$32.53M |
| EPS, basic | -$0.07 | -$1.88 | $0.71 | -$1.03 | -$1.44 | -$0.41 | -$0.20 | -$0.63 | -$0.56 | -$0.56 | -$0.55 | - |
| EPS, diluted | -$0.31 | -$1.88 | -$0.30 | -$0.99 | -$1.44 | -$0.41 | -$0.24 | -$0.63 | -$0.56 | -$0.56 | -$0.55 | - |
| Diluted shares | 162.6M | 135.0M | 130.3M | - | 95.3M | 93.3M | 98.6M | - | 68.4M | 68.4M | 64.2M | - |
Balance sheet
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $443.98M | $433.30M | $466.01M | $149.61M | $185.94M | $221.88M | $260.11M | $165.47M | $206.95M | $228.63M | $262.89M | $220.64M |
| Current assets | $487.55M | $475.67M | $510.87M | $191.49M | $242.39M | $276.40M | $305.47M | $201.29M | $233.66M | $265.09M | $295.51M | $261.30M |
| Total assets | $519.10M | $504.56M | $531.74M | $210.35M | $255.61M | $293.54M | $319.13M | $213.67M | $247.34M | $278.53M | $308.99M | $275.99M |
| Current liabilities | $325.86M | $367.29M | $153.80M | $247.79M | $197.45M | $31.33M | $30.00M | $34.02M | $26.21M | $22.03M | $19.40M | $19.60M |
| Short-term debt | $1.43M | $0 | $0 | $17.52M | $12.67M | $7.98M | $8.99M | $5.51M | $2.16M | - | - | $0 |
| Long-term debt | $49.56M | $50.73M | $50.48M | $14.11M | $18.60M | $22.95M | $21.55M | $24.65M | $27.64M | - | - | $28.76M |
| Total debt | $50.99M | $50.73M | $50.48M | $31.63M | $31.27M | $30.93M | $30.54M | $30.16M | $29.79M | $29.43M | $29.09M | $28.76M |
| Total liabilities | $377.03M | $420.03M | $205.05M | $263.20M | $218.02M | $130.98M | $123.67M | $58.97M | $54.31M | $52.26M | $49.83M | $50.24M |
| Shareholders' equity | $142.07M | $84.53M | $326.69M | -$52.85M | $37.59M | $162.56M | $195.47M | $154.69M | $193.03M | $226.27M | $259.16M | $225.74M |
Cash flow
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$50.77M | -$40.31M | -$47.94M | -$37.79M | -$35.11M | -$38.69M | -$45.66M | -$41.76M | -$22.18M | -$34.42M | -$20.83M | -$27.78M |
| Capital expenditures | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | - | - | - | - | - | - | - | -$41.76M | -$22.18M | -$34.42M | -$20.83M | -$27.78M |
| Investing cash flow | - | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $0 |
| Financing cash flow | $63.09M | $7.56M | $362.45M | $187.0K | $0 | $166.0K | $140.36M | $155.0K | -$53.0K | $210.0K | $63.51M | $41.0K |
| Stock-based compensation | $4.45M | $4.03M | $2.90M | $2.85M | $3.21M | $3.60M | $3.94M | $4.49M | $4.97M | $4.92M | $5.13M | $4.20M |
| Depreciation and amortization | - | - | - | - | - | - | - | - | $59.0K | $63.0K | $61.0K | -$102.0K |
Key ratios
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 1.50 | 1.30 | 3.32 | 0.77 | 1.23 | 8.82 | 10.18 | 5.92 | 8.91 | 12.03 | 15.23 | 13.33 |
| Debt to equity | 0.36 | 0.60 | 0.15 | - | 0.83 | 0.19 | 0.16 | 0.19 | 0.15 | 0.13 | 0.11 | 0.13 |
Source: XBRL data COMPASS Pathways Plc files with the SEC, latest filing dated Nov 3, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
CMPS peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| CMPS | - | - | -$266.30M | - | $1.31B |
| GHRS | - | - | -$48.26M | - | $1.34B |
CMPS FAQ
5 questionsIs CMPS profitable?
No. COMPASS Pathways Plc reported a net loss of $266.30M for the twelve months ended Sep 30, 2026.How much cash and debt does CMPS have?
COMPASS Pathways Plc reported $443.98M in cash and cash equivalents and $50.99M of debt on its most recent balance sheet in SEC filings.What is CMPS earnings per share?
Diluted earnings per share were -$3.48 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.When did CMPS last report financial results?
The latest statements here come from COMPASS Pathways Plc's 10-Q filed on Nov 3, 2026, covering the period ended Sep 30, 2026.Where does this CMPS financial data come from?
Quantisnow builds these statements from the structured XBRL data COMPASS Pathways Plc files with the SEC. It is provided for information only and is not investment advice.